NAV
$60.58
AUM
$120.1M
Expense Ratio
-
Dividend Yield
0.00%
Beta
1.04
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +21.85% | +24.97% | +22.37% | +60.30% | +16.19% | +2.37% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | PRAX | Praxis Precision Medicines Inc Ordinary Shares | 5.55% |
| 2 | ROIV | Roivant Sciences Ltd Ordinary Shares | 4.86% |
| 3 | UTHR | United Therapeutics Corp | 3.33% |
| 4 | THC | Tenet Healthcare Corp | 2.99% |
| 5 | AXSM | Axsome Therapeutics Inc | 2.97% |
| 6 | TNGX | Tango Therapeutics Inc | 2.89% |
| 7 | SLS | SELLAS Life Sciences Group Inc | 2.81% |
| 8 | CELC | Celcuity Inc | 2.75% |
| 9 | BTSG | BrightSpring Health Services Inc | 2.53% |
| 10 | IONS | Ionis Pharmaceuticals Inc | 2.42% |
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or "momentum" characteristics.
Inception Date: 2006-10-12